糖尿病足骨髓炎:病态的微环境和相应的量身定制的治疗策略
Shi-Jiu Yin1, Jia Li2, Yi Ren2
1Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in cell and developmental biology
|March 16, 2026
概括
一种新的微环境匹配策略针对糖尿病足骨髓炎 (DFO) 的感染,炎症和骨缺陷. 这种方法旨在改善愈合和骨再生,为这种具有挑战性的疾病提供新的治疗范式.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 传染性疾病 传染性疾病
背景情况:
- 糖尿病足骨髓炎 (DFO) 呈现为持续性骨感染,由于血液循环受损和局部组织损伤,复发率高.
- 目前涉及脱bridement和抗生素的治疗方法往往不足,导致长时间的恢复和高成本.
- DFO微环境的特点是感染,炎症,氧化应激和骨质生成受损,需要多方面的治疗方法.
研究的目的:
- 审查和提出一个微环境匹配的策略来治疗糖尿病足骨髓炎.
- 通过整合感染控制,炎症调节和骨再生来解决当前DFO疗法的局限性.
- 为DFO提供一个开发先进生物材料和精密护理途径的框架.
主要方法:
- 对多目标抗菌方法的系统审查.
- 对抗炎症和免疫代谢调节策略的分析.
- 评估用于血管生成,神经恢复和骨质再生的多功能生物材料平台.
主要成果:
- 多目标抗菌策略的进步提供了更好的感染控制.
- 生物材料平台正在开发中,以解决炎症,促进血管化,神经修复和骨再生.
- 微环境响应策略可以优化药物输送和时间,以提高治疗结果.
结论:
- 针对感染,炎症和骨缺陷的协调,多目标方法对于有效的DFO治疗至关重要.
- 使用先进生物材料的综合策略有望改善骨重建和愈合耐用性.
- 根据DFO微环境量身定制的精密护理途径可以带来更好的患者结果和降低医疗保健成本.
相关概念视频
Peripheral Artery Disease IV: Nursing Management
538
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
538
Endocarditis III: Medical Management
325
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
325
Diabetes: Management and Pharmacotherapy
1.3K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.3K

